Form 4 for ABT Abbott Laboratories

Accepted 2022-02-23 00:00:00 ET · period of report 2022-02-18 · accession 0001415889-22-001740 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-02-23	2022-02-18	ABT	MANNING JOSEPH J	EVP	A - Grant	$0.00	+15.5K	67.5K	+30%	$0
D	2022-02-23	2022-02-18	ABT	MANNING JOSEPH J	EVP	A - Grant	$0.00	+72.3K	72.3K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common shares without par value	2022-02-18	A	A	15,523	$0.00	67,502	D	—	—	(F1) These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. (F2) Since the date of the reporting person's last ownership report, he transferred 3,754 shares to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.
2	Derivative	Option (right to buy)	2022-02-18	A	A	72,342	$0.00	72,342	D	$117.58 · 2023-02-18 to 2032-02-17	72,342 Common Shares	(F3) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,114 on February 18, 2023, 24,114 on February 18, 2024, and 24,114 on February 18, 2025.